Tauriga Sciences, Inc.
TAUG · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -4.4% | 221.7% | -52.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 54.7% | 44.8% | 54.4% | 58.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $2 |
| SG&A Expenses | $1 | $1 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $2 |
| Operating Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | -1,305.5% | -1,114.3% | -2,925.2% | -2,652.6% |
| Other Income/Exp. Net | -$0 | -$1 | $0 | -$0 |
| Pre-Tax Income | -$2 | -$2 | -$1 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$2 | -$1 | -$2 |
| % Margin | -1,503.5% | -1,617.5% | -2,494.6% | -2,865.8% |
| EPS | -0.005 | -0.008 | -0.003 | -0.011 |
| % Growth | 28.9% | -153.3% | 73.7% | – |
| EPS Diluted | -0.005 | -0.008 | -0.003 | -0.011 |
| Weighted Avg Shares Out | 297 | 283 | 278 | 194 |
| Weighted Avg Shares Out Dil | 297 | 283 | 278 | 194 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$0 | -$2 |
| % Margin | -1,436.7% | -1,225.9% | -1,184.7% | -2,592% |